Using Mismatch Negativity to Investigate the Pathophysiology of Substance Use Disorders and Comorbid Psychosis. (July 2018)

• Record Type: Journal Article
• Authors: Ramlakhan, Jessica U.; Zomorrodi, Reza; Downar, Jonathan; Blumberger, Daniel M.; Daskalakis, Zafiris J.; George, Tony P.; Kiang, Michael; Barr, Mera S.
• Is Part Of: Clinical EEG and neuroscience. Volume 49:Number 4(2018)
• Page Start: 226
• Page End: 237
• Publication Date: 2018-07
• Subjects: substance use disorder -- mismatch negativity -- event-related potential -- biomarker -- psychosis; Electroencephalography -- Periodicals; Neurosciences -- Periodicals; 616.8047547
• DOI: 10.1177/1550059418760077
• Languages: English
• ISSNs: 1550-0594

Abstract

Substance use disorders (SUDs) have a devastating impact on society and place a heavy burden on health care systems. Given that alcohol, tobacco, and cannabis use have the highest prevalence, further understanding of the underlying pathophysiology of these SUDs is crucial. Electroencephalography is an inexpensive, temporally superior, and translatable technique which enables investigation of the pathobiology of SUDs through the evaluation of various event-related potential components, including mismatch negativity (MMN). The goals of this review were to investigate the effects of acute and chronic alcohol, tobacco, and cannabis use on MMN among nonpsychiatric populations and patients with comorbid psychosis. A literature search was performed using the database PubMed, and 36 articles met our inclusion and exclusion criteria. We found a pattern of attenuation of MMN amplitude among patients with alcoholism across acute and chronic alcohol use, and this dysregulation was not heritable. Reports were limited, and results were mixed on the effects of acute and chronic tobacco and cannabis use on MMN. Reports on comorbid SUDs and psychosis were even fewer, and also presented mixed findings. These preliminary results suggest that MMN deficits may be associated with SUDs, specifically alcohol use disorder, and serve as a possible biomarker for treating these common disorders.